As cases of #ColorectalCancer among young people are on the rise, Sheila Rustgi, MD, dispels common misconceptions and explains why early detection - and screening - is so important.
healthmatters.nyp.org/seven-myths-ab…

The reviews are in! Our own Tal Danino's recently published book, 'Beautiful Bacteria: Encounters in the Microuniverse' is a hit!

Get your hands on a copy now👉 📖 bit.ly/49qcRCq

RAS proteins have long been an elusive cancer drug target. New preclinical research in nature from KenOliveLab shows the potential of an entire new class of experimental drugs that could treat almost all forms of pancreatic cancer - and maybe even more.
cuimc.columbia.edu/news/opening-n…

Scientists sometimes are reluctant to show optimism. We don’t want to look foolish if things don’t pan out or risk raising false hope. But hope is powerful medicine. So I’ll say it. Today I am optimistic that change is coming for pancreatic cancer medicine. #hope

🔬 Tomorrow at #AACR24 !
🧬 New research from Michael Shen and Califano Lab reveals how tumor cells adapt to evade targeted therapies in castration-resistant prostate cancer ( #CRPC ) by switching lineages to neuroendocrine features, offering potential therapeutic avenues.

Happening tomorrow at #AACR2024 ! Mary Beth Terry, PhD (Mary Beth Terry) will speak at the “Early-onset Cancers: Challenges and Opportunities for Prevention and Treatment” session, spotlighting the rising incidence of early-onset breast cancer.

Here we are! #AACR24 one more year, same excitement and motivation!! Inspiring Science, Fueling Progress… Revolutionizing care! AACR AACRFoundation #CancerResearch

Sunil Iyer, MD, expands on the potential role of imetelstat for select patients with lower-risk myelodysplastic syndrome. Sunil Iyer, MD Herbert Irving Comprehensive Cancer Center #mpnsm onclive.com/view/imetelsta…

Join editors-in-Chief of Blood Cancer Discovery Riccardo Dalla-Favera, MD and Kenneth C. Anderson, MD for a discussion about the scope of the journal and types of research manuscripts they are seeking to publish. #AACR24

Congratulations to Dr. Rustgi for being awarded the AACR Daniel Von Hoffman award for mentorship in education! Extremely well deserved! Herbert Irving Comprehensive Cancer Center AACR

Early-onset esophagogastric cancer is on the rise - should these patients have different therapeutic strategies? The team (Ryan Moy) used a database of over 5000 patients to identify molecular features and find potential therapeutic opportunities for treatment. #AACR24

New research from the lab of Timothy Wang, MD tomorrow at #AACR24 exploring the efficacy of CXCR4, a partial agonist, in mouse models of advanced gastric cancer.
abstractsonline.com/pp8/#!/20272/p…

Tomorrow at #AACR24 from the Califano Lab and KenOliveLab:

Are RAS inhibitors for pancreatic cancer finally on the horizon? Learn more about a promising new RAS inhibitor and the preclinical study shedding light on potential mechanisms of resistance.
abstractsonline.com/pp8/#!/20272/p…

Come join us at room 28 to discuss oligometastatic disease! Ralph Weichselbaum AACR Herbert Irving Comprehensive Cancer Center The University of Chicago

🚨LATE-BREAKING RESEARCH🚨 from the Rustgi lab shedding light on the molecular mechanisms underlying pancreatic cancer development and suggesting Prrx1 as a potential therapeutic target. Tomorrow at #AACR2024 !
abstractsonline.com/pp8/#!/20272/p…

What drives disparities in pediatric oncology, and what can be done to overcome them? Hear from panelist Justine Kahn MD, MS at tomorrow's symposium at #AACR24 .

🚨LATE-BREAKING RESEARCH🚨
A potential new therapeutic avenue for CRPC-NE, a subtype of metastatic castration-resistant prostate cancer, from the Shen lab (Michael Shen) tomorrow at #AACR2024 .

🔬 Exciting talk at #AACR2024 !
👩‍🔬Alison Taylor, PhD
🧬A genome engineering approach using CRISPR-Cas9 genome editing, computational approaches, and organoid models to understand cancer aneuploidies and potential precision oncology targets for patients.
abstractsonline.com/pp8/#!/20272/p…

Tomorrow at #AACR24 - understanding the mechanisms behind different TP53 mutations in promoting metastasis could lead to new ways to treat ESCC and other SCCs. New research from the Rustgi lab will be presented by Gizem Efe, PhD (Gizem Efe).
abstractsonline.com/pp8/#!/20272/p…

What is the 'oligometastatic state' and could it be curable? Katie Spina (she/her) will explore the scientific and clinical data that aim to define and differentiate oligometastatic cancer as a clinical entity, and potential therapeutic avenues at tomorrow's session. #AACR24